Protean BioDiagnostics to Present at AACR 2021 Annual Meeting

ACCESSWIRE

Wed, Mar 17, 2021, 10:00 AM2 min read

ORLANDO, FL / ACCESSWIRE / March 17, 2021 /Protean BioDiagnostics Inc. ("Protean"), a disruptive biotechnology company developing and commercializing novel cancer diagnostics supporting precision oncology, is pleased to announce that its below-referenced abstract has been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Virtual Annual Meeting, April 10-15 and May 17-21, 2021.

"Targeted therapy for breast cancer requires a better understanding of the role of tumor driving signaling pathways," said Dr. Anthony Magliocco, President, and CEO of Protean. "Leveraging Philips' OncoSignal technology, we show evidence that using certain signaling pathway assays may provide a superior approach to current immunohistochemistry methods to more effectively select patients for specific precision oncology targeted therapy treatments."

Philips' OncoSignal technology has been used to profile the activity of cell signaling pathways in different breast cancer subtypes, leading to a better understanding of what drives tumor growth in these subtypes.

Abstract Title: Breast cancer IHC subtypes display heterogenous and independent targetable signaling pathway activity profiles

Session Type: E-Poster Session

Session Category: Clinical Research (Excluding Trials)

Session Title: Laboratory Correlates for Targeted Agents

Permanent Abstract Number: 533

About Protean BioDiagnostics Inc.

Protean BioDiagnostics is a disruptive biotechnology company developing and commercializing novel cancer diagnostics supporting precision oncology. Protean has created Oncology MAPS™ - a unique and innovative, fully integrated diagnostic system for oncologists. This easy-to-deploy system enables rapid access to precision diagnostics for underserved community-based cancer doctors and their patients wherever they practice. Oncology MAPS includes comprehensive support and access to the latest genetic, molecular, and cancer blood monitoring tests as well as educational and telemedicine support.

Protean is transforming cancer practice using a big data approach which integrates digital pathology, multi-omics, and artificial intelligence. Protean also provides support for contract research, clinical trials, and novel biomarker development using its CAP-accredited, CLIA-certified laboratories and through its extensive client networks.

Companion diagnostics can be quickly evaluated and deployed leveraging Protean's extensive laboratory capabilities, expertise, and extensive global research networks.

CONTACT:

Paul Moon
Paul.moon@proteanbiodx.com
403-390-1676

SOURCE: Protean BioDiagnostics

View source version on accesswire.com:
https://www.accesswire.com/635791/Protean-BioDiagnostics-to-Present-at-AACR-2021-Annual-Meeting

'$2 Million Is Nothing' Suze Orman Warns Don't Retire If You Don't Have At Least $5 Million Or $10 Million Saved
On the "Afford Anything" podcast, Suze Orman delivered a pointed critique on the notion of retiring early with a $2 million portfolio. She was direct in her advice, emphasizing the insufficiency of such an amount for early retirement. "Two million dollars is nothing," Orman declared, "It’s nothing. It’s pennies in today’s world, to tell you the truth." Don't Miss: The average American couple has saved this much money for retirement — How do you compare? Can you guess how many Americans successfu
Benzinga
Can You Guess How Many Americans Have $2 Million Saved For Retirement? It's Probably Less Than You'd Expect
While retiring with a $2 million nest egg might seem rare, it’s closer to what many Americans now believe they need to retire comfortably. A survey from Northwestern Mutual reveals that Americans feel they need $1.46 million for a comfortable retirement, a number that has surged by 53% since 2020. This dramatic increase, influenced by inflation and growing financial pressures, suggests that a $2 million target may not be as far-fetched as it appears, especially for someone who is 60 and plans to
Benzinga
Changes from Visa mean Americans will carry fewer physical credit, debit cards in their wallets
Visa on Wednesday announced major changes to how credit and debit cards will operate in the U.S. in the coming months and years. The new features could mean Americans will be carrying fewer physical cards in their wallets, and will make the 16-digit credit or debit card number printed on every card increasingly irrelevant. “I think (with these features) we’re getting past the point where consumers may never need to manually enter an account number ever again,” said Mark Nelsen, Visa’s global head of consumer payments, in an interview.
Associated Press Finance
Warren Buffett's Berkshire Confirms Apple Sale, Dumps This PC Maker, Finally Reveals Mystery Stock: Here Are The Portfolio Changes To Know
Investment guru Warren Buffett confirmed Wednesday the trimming of his Apple, Inc. (NASDAQ:AAPL) stake and finally shed light on the mystery stock his firm, Berkshire Hathaway, Inc. (NYSE:BRK) (NYSE:BRK), accumulated ahead of the first quarter. Apple, Chevron Trimmed: Berkshire reduced its Apple position by a little over 116 million. The firm now owns 789,368,450 Apple shares valued at $135.36 billion, a 13F filing shows. This is the second straight quarter that the Buffett-led company has dilut
Benzinga
Sam Bankman-Fried Traded In His $35 Million Mansion In The Bahamas For A Prison Cell With 35 Inmates But Claims "He Did Not Do Anything Wrong"
Formerly disgraced FTX CEO and Co-Founder Sam Bankman-Fried was convicted in November of wire fraud, money laundering and conspiracy, and sentenced to 25 years in prison. His high-profile trial marked a significant chapter in the unraveling of FTX, which collapsed under suspicious financial practices, leading to intense scrutiny and legal action. For the first time since his incarceration, Bankman-Fried described his daily life in a detailed interview with journalist William D. Cohan of Puck. Do
Benzinga
'Big Short' Investor Michael Burry Bets Heavy On Gold, Renewable Energy Stocks, Exits Amazon, Alphabet
Michael Burry, the legendary investor who famously predicted the 2008 financial crisis, has once again made headlines with his latest 13F filing for his hedge fund Scion Asset Management LLC. The first quarter of 2024 reveals a strategic recalibration towards physical commodities and renewable energy, while Burry shifted away from some tech giants. The total market value of Scion's 13F securities increased from $94.6 million to $103.49 million. The fund’s activity included five new purchases, ad
Benzinga
Nvidia Dethroned: This AI Chip Stock Now Rules This Elite Screen
Broadcom just ended the reign of Nvidia, usurping the top spot on this list of new buys by the best mutual funds.
Investor's Business Daily
Jamie Dimon says inflation is worse than people think, and that the market is too optimistic about a soft landing
"Inflation may not go away the way people expect it to," the JPMorgan CEO said, adding: "There are a lot of inflationary forces in front of us."
Business Insider
Move Over, Walmart and Chipotle: Wall Street Has a New Stock-Split Stock
A stellar company is set to join an exclusive club of top-tier businesses that have somewhat recently conducted a forward-stock split.
Motley Fool
2 Bank Stocks to Buy With $1,000 and Hold Forever
These two bank stocks are very different. One offers compelling value, while the other is a growth superstar.
Motley Fool

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Protean BioDiagnostics to Present at AACR 2021 Annual Meeting

Recommended Stories

'$2 Million Is Nothing' Suze Orman Warns Don't Retire If You Don't Have At Least $5 Million Or $10 Million Saved

Can You Guess How Many Americans Have $2 Million Saved For Retirement? It's Probably Less Than You'd Expect

Changes from Visa mean Americans will carry fewer physical credit, debit cards in their wallets

Warren Buffett's Berkshire Confirms Apple Sale, Dumps This PC Maker, Finally Reveals Mystery Stock: Here Are The Portfolio Changes To Know

Sam Bankman-Fried Traded In His $35 Million Mansion In The Bahamas For A Prison Cell With 35 Inmates But Claims "He Did Not Do Anything Wrong"

'Big Short' Investor Michael Burry Bets Heavy On Gold, Renewable Energy Stocks, Exits Amazon, Alphabet

Nvidia Dethroned: This AI Chip Stock Now Rules This Elite Screen

Jamie Dimon says inflation is worse than people think, and that the market is too optimistic about a soft landing

Move Over, Walmart and Chipotle: Wall Street Has a New Stock-Split Stock

2 Bank Stocks to Buy With $1,000 and Hold Forever